SEPSF 财务： Asep Medical Holdings Inc AI 分析

主页

股票

SEPSF

SEPSF 财务

Asep Medical Holdings Inc

0%

$0

收盘价：Feb 13, 16:00:00 GMT-5

0%

$0

盘后：Feb 13, 20:00:00 GMT-5

概述预测收益股息财务数据

关键数据

前收盘价

开盘价

当日区间

52周范围

交易量

平均成交量

每股收益（TTM）

股息收益率

市值

什么是 SEPSF？

ASEP Medical Holdings, Inc. engages in the acquisition of assets, technology, and businesses in the area of life sciences and medical diagnostics. The company is headquartered in Victoria, British Columbia. The company went IPO on 2021-11-22. The firm consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. The firm offers a rare combination of both a novel diagnostic and a therapeutic approach. The Company’s lead product was developed through its subsidiary, Sepset Biosciences Inc., which utilizes proprietary diagnostic tools to enable the early and timely identification of sepsis. ABT Innovations Inc. provides broad-spectrum therapeutic agents to address multi-drug resistant biofilm infections. SafeCoat Medical Inc. provides an antimicrobial peptide, anti-fouling medical device coating technology.

功能特性

资源

市场

收入

资产负债表

现金流量

年度

季度性

SEPSF 收入

以百万美元为单位的财务数据。财年为2月至次年1月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021
营收	0	0	0	0	0
营收同比增长 (YoY)	--	--	--	--	--
营收成本	--	--	--	--	--
毛利润	--	--	--	--	--
销售、一般及管理费用	1	2	5	3	1
研发	0	0	0	0	0
营业费用	2	4	7	5	2
其他非经营性收入 (费用)	0	--	--	0	--
税前利润	-12	-13	-9	-5	-2
所得税费用	--	--	0	0	--
净利润	-7	-8	-8	-4	-2
净利润增长	75%	0%	100%	100%	--
稀释后流通股数	11.12	7.6	6.22	6.21	5.61
股份同比变动 (YoY)	46%	22%	0%	11%	--
每股收益 (摊薄)	-0.7	-1.08	-1.32	-0.72	-0.39
每股收益增长率	17%	-18%	82%	87%	--
自由现金流	0	0	-2	-3	-1
每股自由现金流	--	--	--	--	--
毛利率	--	--	--	--	--
营业利润率	0%	0%	0%	0%	0%
净利率	0%	0%	0%	0%	0%
自由现金流利润率	0%	0%	0%	0%	0%
EBITDA	-2	-2	-6	-4	-2
EBITDA 利润率	0%	0%	0%	0%	0%
EBITDA 中的折旧与摊销	0	1	1	1	0
EBIT	-2	-3	-7	-5	-2
EBIT 利润率	0%	0%	0%	0%	0%
有效税率	--	--	0%	0%	--

Asep Medical Holdings Inc（SEPSF）价格

SEPSF 股价走势图